Olaris CEO Elected to Personalized Medicine Coalition Board of Directors

WALTHAM, MA, UNITED STATES - Jun 9, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced that The Personalized Medicine Coalition (PMC) has elected Olaris CEO and Founder Dr

Florence Healthcare Names Melinda Rodriguez Winner of The Florence Effect Initiative

ATLANTA, GA, UNITED STATES - Jun 8, 2020 -  Florence Healthcare, the leading platform for remote-enabled electronic document workflow management in clinical trials, is proud to name Melinda Rodriguez, Director of Regulatory Services at Elligo Health Research, as the winner of The Florence Effect initiative

The RSA Group reveals new global brand

LONDON, UK - Jun 5, 2020 - The RSA Group, the leading global specialist in Life Sciences Executive Search, is excited to share its new global brand and website

BOC Sciences Offers Raw Chemical Materials for Manufacturing Test Kits and Vaccines

SHIRLEY, NY - Jun 5, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical raw material supplier, announced to offer raw chemical materials needed for the manufacture of test kits and vaccines to meet the challenges facing the global pharmaceutical industry during the coronavirus outbreak

Lyniate Facilitates Interoperability Ecosystem via Strategic Partnerships

BOSTON, MA, UNITED STATES - Jun 3, 2020 - Boston, MA - June 3, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced that as part of its effort to create a truly interoperable ecosystem in healthcare, it has partnered with two healthcare technology vendors: BioIntelliSense and HICG

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

KING OF PRUSSIA, PA, UNITED STATES - Jun 2, 2020 - Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up

InSysBio to announce the launch of QSP model of COVID-19

MOSCOW, RUSSIA - Jun 2, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19

UCB and N-SIDE increase their strategic collaboration

LOUVAIN-LA-NEUVE, BELGIUM - Jun 2, 2020 - N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization

Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman

CAMBRIDGE, UK - Jun 2, 2020 - Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

HAIFA, ISRAEL - Jun 2, 2020 -   MeMed Ltd., a leader in host response-based solutions, today announced that it has received a CE Mark in Europe for use of its diagnostic test MeMed BV™ and point-of-need platform MeMed Key™

Almac Clinical Technologies Introduces Simplify™, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up

SOUDERTON, PA, UNITED STATES - Jun 1, 2020 - Almac Clinical Technologies, part of the Almac Group, today announced the availability of SimplifyTM, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations

PHILADELPHIA, PA, UNITED STATES - Jun 1, 2020 - PHILADELPHIA, PA (June 1, 2020)  – Imvax, Inc., a clinical-stage biotechnology company, today announced that Iphigenia (“Effie”) Leonidou Koumenis has been appointed as Head of Clinical Operations

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

NOTTINGHAM, UNITED KINGDOM - Jun 1, 2020 -   Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020

Accumen Launches Hospital Lab Crisis Preparedness Program

PHOENIX, AZ - May 29, 2020 - Accumen Inc. is helping healthcare get better, faster. As an extension of its ongoing effort to provide resources that enable hospitals to manage every phase of the COVID-19 pandemic optimally, today Accumen launched its Lab Crisis Preparedness Program to help hospitals ensure their laboratories are able to meet the testing needs of their health system and surrounding communities

Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®

IRVINE, CALIF., U.S., AND AMSTERDAM, NETHERLANDS - May 29, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial designed to further demonstrate the clinical utility of MammaPrint® risk scoring when determining a breast cancer patient’s need for chemotherapy

Shivom Launches FREE Informatics – Secure Health Data Sharing Solutions to Organisations Studying COVID-19.

LONDON, UNITED KINGDOM - May 29, 2020 -  Shivom Ventures Limited “Shivom” today announced the startup will be playing its part in combating the deadly coronavirus disease by offering researchers and pharmaceutical companies a 1-year free subscription to interrogate both viral and human genomes separately from RAW sequencing data

BOC Sciences Adds Featured SARS-CoV-2 Inhibitors for Drug Discovery

SHIRLEY, NY, UNITED STATES - May 29, 2020 - In recent days, BOC Sciences, one of the world’s leading chemical and pharmaceutical provider, announced to add more than 100 inhibitors of SARS-CoV-2 to its present inhibitor base to help the drug discovery of scientific research institutions during the COVID-19 pandemic

Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle

MANCHESTER, UNITED KINGDOM - May 28, 2020 -  

• The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors

• Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses

• Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx

CD Genomics Launches NGS Panels for SARS-CoV-2 Detection and Research

SHIRLEY, NY, UNITED STATES - May 20, 2020 - CD Genomics has developed a very comprehensive NGS panels for sequencing, coronaviruses detection, phylogenetic analysis and molecular characterization of the 2019 novel coronavirus (namely SARS-CoV-2, and the virus is responsible for COVID-19)

ERT helps medical researchers accelerate clinical trials with AI-assistance from Dynatrace

WALTHAM, MA, UNITED STATES - May 28, 2020 - Software intelligence company Dynatrace (NYSE: DT), today announced that ERT – a developer of software and devices used by medical researchers in 75% of FDA approved clinical trials in 2019 – is using Dynatrace® to automate DevOps processes, and speed up delivery of new applications, from an average of six weeks to as little as two weeks